Source: Virtual Congress 2020 – Bronchoscopic treatments for COPD and Emphysema
Disease area: Airway diseases



Rating:

Share or cite this content

Citations should be made in the following way:
R. Eberhardt (Heidelberg, Germany), F. Herth (Heidelberg, Germany). Targeted lung denervation: COPD. Virtual Congress 2020 – Bronchoscopic treatments for COPD and Emphysema

Member's Comments

No comment yet.

Related content which might interest you: Targeted lung denervation: interventions in moderate COPD patients Source: International Congress 2019 – Interventional pneumology: live out of the box round two Year: 2019 Targeted lung denervation Source: International Congress 2018 – Endoscopic solutions for obstructive lung diseases Year: 2018 Importance of surface cooling during targeted lung denervation for COPD Source: International Congress 2014 – Animal models in respiratory drug development Year: 2014 Targeted lung denervation in the healthy sheep model - A potential treatment for COPD Source: International Congress 2014 – Rationale behind respiratory drug development Year: 2014 Anti-inflammatory effects of targeted lung denervation in patients with COPD Source: Eur Respir J 2015; 46: 1489-1492 Year: 2015 Targeted Lung Denervation modulates the bronchial epithelial transcriptome in COPD Source: International Congress 2019 – Bronchoscopic treatment of COPD: hot news Year: 2019 Target lung denervation (TLD) for COPD Source: Virtual Congress 2021 – Interventional pulmonology Year: 2021 Pre-treatment lung function decline stabilizes up to 3 year after targeted lung denervation in COPD Source: Virtual Congress 2020 – The hot and cold of interventional pulmonology Year: 2020 Long-term safety of bilateral targeted lung denervation in patients with COPD in a single procedure Source: International Congress 2015 – Bronchoscopic treatment of COPD and asthma: valves, coils, thermoplastics and something more Year: 2015 Effects of transplantation on lung and exercise physiology Source: ISSN=1025-448x, ISBN=1-904097-29-4, page=220 Year: 2003 The EvA-Study: Markers of emphysema versus airway disease in COPD Source: Annual Congress 2009 - EU Research Programmes: 1.GABRIEL 2.EvA 3.COPACETIC Year: 2009 Additive effect of targeted lung denervation plus drug in patients with COPD Source: International Congress 2015 – Novel treatments for cough, asthma, COPD and bronchiectasis Year: 2015 Anti-inflammatory effects of targeted lung denervation in patients with COPD Source: International Congress 2014 – Novel approaches and evidence for drug development in respiratory diseases Year: 2014 Treatment of combined pulmonary fibrosis and emphysema Source: International Congress 2016 – Novel avenues in the treatment of COPD II Year: 2016 Role of soluble α-klotho on lung and skeletal muscle function in chronic obstructive pulmonary disease Source: International Congress 2016 – Recent high impact findings regarding COPD comorbidities Year: 2016